| Date | Title | Description | |
|---|---|---|---|
| 21 Oct 2025 | On business and financial situation | The Company releases the press release in relation to the announcement of the collaboration with Roche for the manufacture of a new medicine in development | Download | 
| 29 Sep 2025 | On corporate transactions: mergers, acquisitions and others | The Company releases the presentation related to the acquisition of an injectable drug product manufacturing site in Phoenix, Arizona (USA) | Download | 
| 29 Sep 2025 | On corporate transactions: mergers, acquisitions and others | ROVI announces the acquisition of an injectable drug product manufacturing site in Phoenix, Arizona (USA) | Download | 
| 24 Jul 2025 | On P&L | The Company releases the press release related to the first half of 2025 financial results | Download | 
| 24 Jul 2025 | On P&L | The Company releases the first half 2025 financial results presentation | Download | 
Pages
| Date | Title | Description | |
|---|---|---|---|
| 15 Feb 2022 | On business and financial situation | ROVI has announced that the European Commission has authorised the marketing of Okedi® for the treatment of schizophrenia in adults for whom tolerability and effectiveness has been established with oral risperidone. | Download | 
| 14 Feb 2022 | Share buy-back , stabilisation and treasury stock programme | Share Buyback Program: transactions conducted between 7 February 2022 and 11 February 2022 | Download | 
| 07 Feb 2022 | Share buy-back , stabilisation and treasury stock programme | Share Buyback Program: transactions conducted between 31 January 2022 and 4 February 2022 | Download | 
| 31 Jan 2022 | Share buy-back , stabilisation and treasury stock programme | Share Buyback Program: transactions conducted between 24 January 2022 and 28 January 2022 | Download | 
| 24 Jan 2022 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted between 17 January 2022 and 21 January 2022 | Download | 
Pages
| Date | Title | Description | |
|---|---|---|---|
| 25 Jul 2017 | Otros sobre Gobierno Corporativo | The Company informes about the modification of the Internal code of conduct | Download | 
| 10 Jul 2017 | Contratos de liquidez y contrapartida (2) | The Company informs that has signed a new liquidity contract with JB Capital Markets, Sociedad de Valores, S.A.U. | Download | 
| 10 Jul 2017 | Contratos de liquidez y contrapartida (1) | The Company informs that has cancelled the liquidity contract with JB Capital Markets, Sociedad de Valores, S.A.U. | Download | 
| 04 Jul 2017 | Contratos de liquidez y contrapartida | Liquidity contract: transactions conducted in the second quarter of 2017 | Download | 
| 23 Jun 2017 | Información sobre dividendos | The Company informes about the dividends payment | Download | 







